An esterase-activatable curcumin prodrug for tumor-targeting therapy-Reference-Cited by-同舟云学术

An esterase-activatable curcumin prodrug for tumor-targeting therapy

Published:2022 Issue:96 Volume:58 Page:13329-13332
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Liu Li¹,Zhang Lele¹,Tao Menglin¹,Wang Minghui¹,Dong Ling²,Hai Zijuan¹^ORCID

Affiliation:

1. Key Laboratory of Structure and Functional Regulation of Hybrid Materials, Ministry of Education, Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, China

2. Department of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230601, China

Abstract

Armed with a tumor-targeting RGD peptide and an in situ esterase-triggered drugrelease, prodrug Cur-RGD can efficiently improve the therapeutic effect ofcurcumin in tumors.

Funder

Anhui Provincial Department of Science and Technology

National Natural Science Foundation of China

Natural Science Foundation of Anhui Province

Anhui Provincial Department of Education

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2022/CC/D2CC03952D

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy

3. Choline phosphate lipid insertion and rigidification of cell membranes for targeted cancer chemo-immunotherapy

4. Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA functional control by hydrolysis reversible acylation;2024-08-30